FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200204855> ?p ?o ?g. }

• W4200204855 endingPage "103476" @default.
• W4200204855 startingPage "103476" @default.
• W4200204855 abstract "Fatigue is one of the most frequent symptoms of persons with Multiple Sclerosis (pwMS) but has limited treatment options. Aerobic capacity and endurance training have been discussed as relevant factors to improve fatigue. However, over the last decades, results have been equivocal. This secondary analysis of two pooled parallel group RCTs of three weeks of endurance training (high intensity interval training (HIIT) and moderate continuous training (MCT)) for pwMS aimed to (I) reproduce reported associations between aerobic capacity and fatigue on a cross-sectional and interventional level. The analysis further aimed to (II) investigate intervention effects on fatigue in a severely fatigued subgroup and (III) analyze differences in changes of fatigue between peak oxygen uptake (VO2peak) responders and non-responders.Both RCTs were conducted in the same inpatient rehabilitation clinic in Valens, Switzerland. Original primary outcomes were cognitive function (RCT1) and change in proportion of circulating regulatory T-cells (RCT2). PwMS (n = 131) with a relapsing-remitting or secondary progressive MS phenotype and Expanded Disability Status Scale score between 1 - 6.5 were eligible. Over the two studies participants exercised 3 - 5 times per week on cycle ergometers at intensities of 65 - 70% of maximum heart rate (HRmax) for 30 min (MCT groups) or three times per week with five 90 - 180 s intervals at intensities of 85% - 100% of HRmax and 90 s rest intervals (HIIT groups). Main outcome measures for the present secondary analysis were VO2peak measured during a cardiopulmonary exercise test and the Fatigue Scale for Motor and Cognitive Functions (FSMC), both assessed at the start and end of inpatient rehabilitation.Baseline correlations did not reveal a significant association between VO2peak and FSMC. There were no significant improvements in fatigue after the HIIT and MCT in the overall sample or the subsample of severely fatigued pwMS and no significant differences in fatigue changes between VO2peak-responders and non-responders.Our analysis did not confirm the aerobic capacity - fatigue relationship on a cross-sectional and experimental level, even when analyzing subgroups that should benefit the most according to proposed hypotheses." @default.
• W4200204855 created "2021-12-31" @default.
• W4200204855 creator A5011268087 @default.
• W4200204855 creator A5016902287 @default.
• W4200204855 creator A5024639097 @default.
• W4200204855 creator A5025342000 @default.
• W4200204855 creator A5025632428 @default.
• W4200204855 creator A5044169049 @default.
• W4200204855 creator A5045432608 @default.
• W4200204855 creator A5055846558 @default.
• W4200204855 creator A5072059985 @default.
• W4200204855 creator A5076158559 @default.
• W4200204855 date "2022-02-01" @default.
• W4200204855 modified "2023-10-14" @default.
• W4200204855 title "The aerobic capacity – fatigue relationship in persons with Multiple Sclerosis is not reproducible in a pooled analysis of two randomized controlled trials" @default.
• W4200204855 cites W1992731626 @default.
• W4200204855 cites W2004907498 @default.
• W4200204855 cites W2010072109 @default.
• W4200204855 cites W2011810065 @default.
• W4200204855 cites W2063848046 @default.
• W4200204855 cites W2122545833 @default.
• W4200204855 cites W2158177758 @default.
• W4200204855 cites W2159092433 @default.
• W4200204855 cites W2166354070 @default.
• W4200204855 cites W2312572125 @default.
• W4200204855 cites W2471809774 @default.
• W4200204855 cites W2568219228 @default.
• W4200204855 cites W2613585487 @default.
• W4200204855 cites W2620358687 @default.
• W4200204855 cites W2670441571 @default.
• W4200204855 cites W2750436552 @default.
• W4200204855 cites W2754321750 @default.
• W4200204855 cites W2793516715 @default.
• W4200204855 cites W2795312604 @default.
• W4200204855 cites W2884177512 @default.
• W4200204855 cites W2892197227 @default.
• W4200204855 cites W2938015522 @default.
• W4200204855 cites W2939879352 @default.
• W4200204855 cites W2964779192 @default.
• W4200204855 cites W2970086534 @default.
• W4200204855 cites W3138197752 @default.
• W4200204855 cites W3143215102 @default.
• W4200204855 cites W3157526824 @default.
• W4200204855 doi "https://doi.org/10.1016/j.msard.2021.103476" @default.
• W4200204855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35065407" @default.
• W4200204855 hasPublicationYear "2022" @default.
• W4200204855 type Work @default.
• W4200204855 citedByCount "2" @default.
• W4200204855 countsByYear W42002048552022 @default.
• W4200204855 crossrefType "journal-article" @default.
• W4200204855 hasAuthorship W4200204855A5011268087 @default.
• W4200204855 hasAuthorship W4200204855A5016902287 @default.
• W4200204855 hasAuthorship W4200204855A5024639097 @default.
• W4200204855 hasAuthorship W4200204855A5025342000 @default.
• W4200204855 hasAuthorship W4200204855A5025632428 @default.
• W4200204855 hasAuthorship W4200204855A5044169049 @default.
• W4200204855 hasAuthorship W4200204855A5045432608 @default.
• W4200204855 hasAuthorship W4200204855A5055846558 @default.
• W4200204855 hasAuthorship W4200204855A5072059985 @default.
• W4200204855 hasAuthorship W4200204855A5076158559 @default.
• W4200204855 hasConcept C103038586 @default.
• W4200204855 hasConcept C118552586 @default.
• W4200204855 hasConcept C126322002 @default.
• W4200204855 hasConcept C168563851 @default.
• W4200204855 hasConcept C1862650 @default.
• W4200204855 hasConcept C187960798 @default.
• W4200204855 hasConcept C196310339 @default.
• W4200204855 hasConcept C2777953023 @default.
• W4200204855 hasConcept C2777973682 @default.
• W4200204855 hasConcept C2778818304 @default.
• W4200204855 hasConcept C2780640218 @default.
• W4200204855 hasConcept C2780892749 @default.
• W4200204855 hasConcept C2992361435 @default.
• W4200204855 hasConcept C44249647 @default.
• W4200204855 hasConcept C71924100 @default.
• W4200204855 hasConcept C84393581 @default.
• W4200204855 hasConcept C99508421 @default.
• W4200204855 hasConceptScore W4200204855C103038586 @default.
• W4200204855 hasConceptScore W4200204855C118552586 @default.
• W4200204855 hasConceptScore W4200204855C126322002 @default.
• W4200204855 hasConceptScore W4200204855C168563851 @default.
• W4200204855 hasConceptScore W4200204855C1862650 @default.
• W4200204855 hasConceptScore W4200204855C187960798 @default.
• W4200204855 hasConceptScore W4200204855C196310339 @default.
• W4200204855 hasConceptScore W4200204855C2777953023 @default.
• W4200204855 hasConceptScore W4200204855C2777973682 @default.
• W4200204855 hasConceptScore W4200204855C2778818304 @default.
• W4200204855 hasConceptScore W4200204855C2780640218 @default.
• W4200204855 hasConceptScore W4200204855C2780892749 @default.
• W4200204855 hasConceptScore W4200204855C2992361435 @default.
• W4200204855 hasConceptScore W4200204855C44249647 @default.
• W4200204855 hasConceptScore W4200204855C71924100 @default.
• W4200204855 hasConceptScore W4200204855C84393581 @default.
• W4200204855 hasConceptScore W4200204855C99508421 @default.
• W4200204855 hasLocation W42002048551 @default.
• W4200204855 hasLocation W42002048552 @default.
• W4200204855 hasOpenAccess W4200204855 @default.
• W4200204855 hasPrimaryLocation W42002048551 @default.

• next